Latest News

  • PARIS, France and CAMBRIDGE, MA, USA  – Sanofi and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for the treatment of rare genetic diseases. Specifically: Sanofi will obtain global development and commercialization rights...
  • VANCOUVER, British Columbia – Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, provided key accomplishments from the past year and announced priorities for 2018. “2017 was a great year for Zymeworks and we are poised to achieve a number of important corporate milestones in 2018,” said Ali Tehrani,...


Rare disease spotlight


"Mi empresa continúa su actividad y tengo que ir a trabajar,¿qué derechos tengo?,¿Mi empresa me puede obligar a salir e ir a mi centro de trabajo,¿Puedo negarme a ir a trabajar porque temo contagiarme por Covid-19?"
@FEDER_ONG reúne las respuestas aquí:

Just 2 weeks to go...
The #bRED4Porphyria campaign aims to connect the whole porphyria community in these unsettling times… you’re not alone, lets share our videos/photos/stories, connect & have a little fun!

My week on Twitter 🎉: 3 Mentions, 16 Mention Reach. See yours with

My week on Twitter 🎉: 2 Mentions, 732 Mention Reach, 9 Likes, 1 Retweet, 59 Retweet Reach. See yours with

Load More...